10–15% of Head and Neck Cancer Patients Face Recurrence

Approximately 10–15% of patients treated for head and neck cancer experience a recurrence of the disease, according to data highlighted during World Head and Neck Cancer Day.

The Indian Practitioner reports that early detection remains a critical factor in reducing the long-term healthcare burden for patients diagnosed with these malignancies.

Medical experts emphasize the importance of ongoing monitoring and advanced diagnostic testing to manage potential relapses and improve patient outcomes in the Indian healthcare context.